Salivary Immune/Stress Biomarkers Among Children
OPI2
1 other identifier
observational
50
1 country
1
Brief Summary
Background: The use of easily accessible biomarkers for assessing young patients' health is important. This study's aim is a measuring stress/immune biomarkers in saliva of healthy school-age children and compare subgroups according to age, sex, stress perception in dental pain related to symptomatic irreversible pulpitis (SIP) and symptomatic apical periodontitis (SAP). Material and methods: 50 children diagnosed with SIP and SAP aged from 6 to 12 years old will be treated with root canal treatment. Dental examination using DMF score and oral hygiene level will be performedby experienced dentists. Salivary samples will be collected three times: before treatment in day of first dental visit (1), after two weeks (2), and after next two weeks = 30 days (3). Additionally, pain and stress perception will be examined by VAS scale and questionnaires dedicated for children anxiety: Frankl behavior rating scale, Venham's anxiety and behavior rating scale. Salivary immunoglobullins A, G, M, opiorphin, free cortisol and amylase will be measured using commercially available ELISA kits. Results will assess which of the measured salivary biomarkers is related to stress and dental pain, suggesting its use for evaluating in non-invasive way in childhood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 19, 2021
CompletedFirst Posted
Study publicly available on registry
August 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedAugust 25, 2021
August 1, 2021
8 months
August 19, 2021
August 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
dental pain
Proportion of subjects showing no increase in dental pain
30 days
salivary biomarkers
Proportion of subjects showing no increase in salivary biomarkers
30 days
dental anxiety
Proportion of subjects showing no increase in stress perception
30 days
Study Arms (1)
Group
50 generally healthy children diagnosed with dental pain as symptomatic irreversible pulpitis (SIP) or symptomatic apical periodontitis (SAP) aged from 6 to 12 years old will be included to the GROUP.
Interventions
Non-invasive diagnosis of dental pain, dental root canal treatment, salivary specimen collection from the first visit to next and the last during 4 weeks of dental care
Eligibility Criteria
Subjects will be recruited at University dental clinic in Child and Adolescent Section, one experienced dentist will conduct all dental and salivary collection procedures.
You may qualify if:
- male or female
- age 6 - 12 y.o.
- complaint dental pain
- diagnosis of symptomatic irreversible pulpitis or symptomatic apical periodontitis
- assigned agreement to the informed consent form by parents/caregivers and children cooperation
You may not qualify if:
- use of analgesics or antibiotics prior 48 h before specimen collection
- having a systemic disease
- disorders interfering with salivary function or flow
- regular medication intake interfering with salivary function or flow
- having temporary infectious disease
- having neurodevelopmental dysfunction (e.g ADHD)
- lack of cooperation during dental visits
- inability to understand the content of the informed consent form by parents/caregivers and children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Poznan University of Medical Sciences
Poznan, 60-812, Poland
Related Publications (3)
Paszynska E, Roszak M, Slopien A, Boucher Y, Dutkiewicz A, Tyszkiewicz-Nwafor M, Gawriolek M, Otulakowska-Skrzynska J, Rzatowski S, Dmitrzak-Weglarz M. Is there a link between stress and immune biomarkers and salivary opiorphin in patients with a restrictive-type of anorexia nervosa? World J Biol Psychiatry. 2020 Mar;21(3):220-229. doi: 10.1080/15622975.2019.1593502. Epub 2019 Apr 23.
PMID: 30880537BACKGROUNDBoucher Y, Braud A, Dufour E, Agbo-Godeau S, Baaroun V, Descroix V, Guinnepain MT, Ungeheuer MN, Ottone C, Rougeot C. Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study. Clin Oral Investig. 2017 Sep;21(7):2157-2164. doi: 10.1007/s00784-016-1991-0. Epub 2016 Nov 10.
PMID: 27834029BACKGROUNDSlavish DC, Szabo YZ. The effect of acute stress on salivary markers of inflammation: a systematic review protocol. Syst Rev. 2019 May 2;8(1):108. doi: 10.1186/s13643-019-1026-4.
PMID: 31046830RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elzbieta Paszynska, Prof
Poznan University of Medical Sciences, Poland
- STUDY CHAIR
Yves Boucher, Prof
Université de Paris & Groupe Hospitalier Pitié Salpêtrière, 75006 Paris, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
August 19, 2021
First Posted
August 25, 2021
Study Start
August 1, 2021
Primary Completion
March 30, 2022
Study Completion
June 30, 2022
Last Updated
August 25, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share
we do not plan any individual participant data available share to other researchers